Benedict Financial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.01M Buy
76,849
+1,368
+2% +$110K 1.17% 22
2026
Q1
$6.54M Sell
75,481
-476
-0.6% -$45.6K 1.36% 19
2025
Q4
$7.3M Buy
75,957
+283
+0.4% +$27.5K 1.54% 16
2025
Q3
$7.21M Buy
75,674
+487
+0.6% +$44.8K 1.56% 17
2025
Q2
$6.55M Buy
75,187
+429
+0.6% +$36.4K 1.48% 19
2025
Q1
$6.72M Buy
74,758
+1,001
+1% +$89.6K 1.56% 18
2024
Q4
$5.89M Buy
73,757
+243
+0.3% +$21K 1.43% 20
2024
Q3
$6.62M Buy
73,514
+1,044
+1% +$87.8K 1.56% 16
2024
Q2
$5.7M Buy
72,470
+944
+1% +$77.4K 1.45% 19
2024
Q1
$6.23M Buy
71,526
+1,197
+2% +$102K 1.58% 16
2023
Q4
$5.79M Buy
70,329
+358
+0.5% +$27.3K 1.58% 15
2023
Q3
$5.48M Buy
69,971
+791
+1% +$66.2K 1.58% 14
2023
Q2
$6.09M Buy
69,180
+1,974
+3% +$170K 1.68% 14
2023
Q1
$5.42M Buy
67,206
+3,203
+5% +$261K 1.53% 17
2022
Q4
$4.97M Buy
64,003
+3,005
+5% +$244K 1.48% 21
2022
Q3
$4.93M Buy
60,998
+714
+1% +$64.2K 1.58% 15
2022
Q2
$5.41M Buy
60,284
+911
+2% +$92.3K 1.6% 18
2022
Q1
$6.59M Sell
59,373
-21
-0% -$2.22K 1.76% 11
2021
Q4
$6.14M Buy
59,394
+334
+0.6% +$38.7K 1.6% 13
2021
Q3
$7.4M Sell
59,060
-707
-1% -$91.5K 2.07% 8
2021
Q2
$7.42M Sell
59,767
-536
-0.9% -$67.3K 2.06% 7
2021
Q1
$7.12M Sell
60,303
-347
-0.6% -$40.7K 2.06% 7
2020
Q4
$7.1M Buy
60,650
+465
+0.8% +$51.2K 2.56% 7
2020
Q3
$6.25M Buy
60,185
+1,083
+2% +$109K 2.41% 7
2020
Q2
$5.42M Buy
59,102
+206
+0.3% +$19.8K 2.24% 8
2020
Q1
$5.31M Buy
58,896
+195
+0.3% +$20.7K 2.5% 7
2019
Q4
$6.66M Buy
58,701
+135
+0.2% +$14.8K 2.6% 6
2019
Q3
$6.36M Buy
58,566
+144
+0.2% +$15K 2.61% 6
2019
Q2
$5.69M Buy
58,422
+1,149
+2% +$105K 2.37% 6
2019
Q1
$5.22M Sell
57,273
-92
-0.2% -$8.23K 2.26% 8
2018
Q4
$5.22M Sell
57,365
-609
-1% -$56.9K 2.58% 6
2018
Q3
$5.7M Buy
57,974
+80
+0.1% +$7.4K 2.56% 6
2018
Q2
$4.96M Sell
57,894
-115
-0.2% -$9.61K 2.45% 6
2018
Q1
$4.65M Sell
58,009
-169
-0.3% -$13.9K 2.34% 9
2017
Q4
$4.7M Sell
58,178
-761
-1% -$60.9K 2.26% 9
2017
Q3
$4.58M Buy
58,939
+198
+0.3% +$16.4K 2.35% 10
2017
Q2
$5M Sell
58,741
-137
-0.2% -$11.6K 2.6% 7
2017
Q1
$4.74M Buy
58,878
+411
+0.7% +$32.1K 2.58% 7
2016
Q4
$4.17M Buy
58,467
+308
+0.5% +$24.2K 2.41% 8
2016
Q3
$5.02M Sell
58,159
-84
-0.1% -$7.32K 2.93% 5
2016
Q2
$5.07M Sell
58,243
-470
-0.8% -$38K 2.97% 4
2016
Q1
$4.4M Sell
58,713
-264
-0.4% -$19.9K 2.68% 7
2015
Q4
$4.54M Sell
58,977
-380
-0.6% -$28.6K 2.88% 5
2015
Q3
$3.97M Sell
59,357
-326
-0.5% -$24K 2.76% 5
2015
Q2
$4.58M Sell
59,683
-1,210
-2% -$92.4K 2.98% 4
2015
Q1
$4.75M Sell
60,893
-399
-0.7% -$30.2K 3.05% 3
2014
Q4
$4.56M Buy
+61,292
New +$4.26M 2.99% 6

Other funds holding MDT

Benedict Financial Advisors's MDT Position: Q2 2026 in Review

Benedict Financial Advisors increased its Medtronic (MDT) stake by 1.8% in Q2 2026, buying an estimated $110K and bringing the position to 76,849 shares worth $6.01M. The position accounts for 1.17% of the portfolio, ranked #22.

Benedict Financial Advisors first reported a position in MDT in Q4 2014 and has held it in 47 quarters since. The position peaked at $7.42M in Q2 2021. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Benedict Financial Advisors held 76,849 shares of Medtronic worth $6.01M as of Q2 2026.
  • Benedict Financial Advisors bought 1,368 Medtronic shares in Q2 2026, an estimated $110K.
  • Medtronic made up 1.17% of Benedict Financial Advisors's portfolio in Q2 2026, its #22 holding.
  • Benedict Financial Advisors first reported a position in Medtronic in Q4 2014 and has held it in 47 quarters since.
  • Benedict Financial Advisors's Medtronic position peaked at $7.42M in Q2 2021.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Benedict Financial Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.